FDA Inspection
Sircle Laboratories, L.L.C.Sircle Laboratories, L.L.C. – FDA Inspection, Apr 26, 2021
Record Details
This FDA Inspection record concerns Sircle Laboratories, L.L.C., with an inspection on April 26, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sircle Laboratories, L.L.C.
- Inspection Date
- April 26, 2021
- Product Type
- Drugs
View Company Profile
ID · de6edd97-a9ba-4734-9df3-55c6d2ea62ff
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1140698
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.122(a)Written procedures describing in detail
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sircle Laboratories, L.L.C.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sircle Laboratories, L.L.C.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.